Home›Companies›Biotech & Pharma›EPOCH Epigenetics

EPOCH Epigenetics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 16, 2025·Suggest an edit

About EPOCH Epigenetics

EPOCH Epigenetics is a private company based in Baltimore, Maryland, incorporated in 2023 in Delaware. It has reported $72,500 raised in one offering on Form D since June 2025. Its chief executive is Joseph Swiader.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 20, 2025Jun 16, 2025$72,500of $3.0M target1$72,500DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on EPOCH Epigenetics's Form D filed Jun 16, 2025.

EG
Eric Van Gieson
Executive officer and director
NH
Neil Hermansen
Executive officer and director
JS
Joseph Swiader
Chief Executive Officer and director

Sources

  1. SECEPOCH Epigenetics, Inc. filing history